The COVID-19 vaccine market rally has significantly boosted stocks, particularly in travel-related sectors, as Pfizer's vaccine shows over 90% effectiveness. However, concerns about long-term profitability and vaccination hesitancy may hinder a sustained market recovery. Ultimately, successful economic revitalization hinges on widespread vaccination and achieving herd immunity.